Evidence map›Paper›PMID 40317250›Full record

ReviewTherapeutic advances in respiratory disease

Treatable traits in interstitial lung disease: a narrative review.

Megan Harrison, Chloe Lawler, Fiona Lake, Vidya Navaratnam, Caitlin Fermoyle, Yuben Moodley, Tamera J Corte

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Therapeutic advances in respiratory disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Megan HarrisonFaculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.ORCID 0000-0003-1491-1270
Chloe LawlerFaculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
Fiona LakeDepartment of Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.
Vidya NavaratnamDepartment of Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.
Caitlin FermoyleThe University of Sydney, Sydney, NSW, Australia.
Yuben MoodleyFaculty of Medicine and Health, University of Western Australia, Nedlands, WA, Australia.
Tamera J CorteFaculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The interstitial lung diseases (ILDs) are a heterogeneous and complex group of diseases. The treatable trait (TT) model represents a shift in ILD management, away from traditional diagnostic labels towards a more individualised, trait-focused approach. This review explores the application of the TT paradigm to ILD, identifying key traits across the aetiological, pulmonary, extrapulmonary and behavioural domains. By addressing these traits, the TT model offers a framework to improve outcomes in ILD through multidisciplinary management with a precision medicine focus. Further research is necessary to evaluate the overall impact of this TT model on ILD care.

Indexed as

LungLung Diseases, InterstitialPrecision MedicineHumansPhenotypeTreatment Outcomecomprehensive careinterstitial lung diseasemodel of caremultidisciplinarytreatable traits

Identifiers

PMID40317250
PMCPMC12049629

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.